Choksi Laboratories Limited has successfully concluded its postal ballot voting process on April 26, 2026, with shareholders demonstrating strong support for the company's governance initiatives. The pharmaceutical company announced the completion of remote e-voting for special resolutions under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Postal Ballot Process Details

The remote e-voting process was conducted over a month-long period, providing shareholders ample opportunity to participate in the decision-making process. The voting timeline and key parameters are outlined below:

Voting Results and Shareholder Participation

The special resolution regarding the appointment of Mr. Ritik Pavecha (DIN: 08790431) as Non-Executive Independent Director received overwhelming approval from shareholders. The voting results demonstrate strong confidence in the proposed appointment:

The overall voter turnout stood at 20.87% of the total eligible shares, with 99.86% of polled votes supporting the resolution. Only 2001 votes were cast against the proposal, representing merely 0.14% of the total votes polled. The promoter/promoter group confirmed they were not interested in this agenda/resolution.

Scrutinizer's Report and Compliance

CS Surabhi Agrawal from Surabhi Agrawal & Associates served as the appointed scrutinizer for the postal ballot process. The scrutinizer's report confirmed the fair and transparent conduct of the remote e-voting process through the CDSL platform. The report validated that all procedural requirements under Sections 108 and 110 of the Companies Act, 2013, and relevant SEBI regulations were duly followed.

The scrutinizer emphasized that the voting process was conducted in compliance with Companies Act, 2013 and associated rules, SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, MCA circulars and guidelines, and electronic voting system security frameworks. The votes were unblocked on April 26, 2026 at 05:00 PM after the conclusion of the meeting and witnessed by Ms. Vaishnavi Dhone and Ms. Anishi Dammani, who are not in the employment of the company.

Board Appointment Details

The approved resolution pertains to the appointment of Mr. Ritik Pavecha, bearing Director Identification Number 08790431, as a Non-Executive Independent Director of the company. This appointment aligns with corporate governance best practices and regulatory requirements for board composition. The resolution was classified as a special resolution, requiring higher approval thresholds, which the company successfully achieved.

Corporate Communication

Prakhar Dubey, Company Secretary and Compliance Officer, signed the official communication to BSE Limited on April 28, 2026, formally notifying the stock exchange of the voting results. The company maintains its registered office at Office No. 102, 02nd Floor, Mishika Tower, Sneh Nagar, Indore, while its corporate office and central laboratory are located at Survey No 9/1, Near Tulsiyana Industrial Park, Gram Kumerdi, Indore. The scrutinizer's report was dated April 27, 2026, with UDIN: F013816H000211519.

Choksi Laboratories Limited has officially communicated to the Bombay Stock Exchange (BSE) regarding its non-applicability under SEBI's framework for fund raising through debt securities by large entities. The company confirmed on April 15, 2026, that it does not meet the criteria for 'Large Corporate' classification under the regulatory framework.

Regulatory Framework Details

The communication references multiple regulatory documents that govern debt securities issuance by large entities:

Compliance Confirmation

The company has confirmed that since it does not fall under the 'Large Corporate' category as per the SEBI framework, the requirement of filing Annual Disclosure in Annexure B2 for the year ended March 31, 2026 does not apply. This exemption relieves the company from specific disclosure obligations mandated for larger entities in the debt securities space.

Corporate Communication

The formal communication was signed by Prakhar Dubey, Company Secretary and Compliance Officer, and submitted to BSE for record-keeping and publication on the exchange's website for investor information. The company has requested BSE to take the information on record and make it available to investors and members through the exchange's official website.

Company Information

This regulatory compliance confirmation ensures transparency with stakeholders regarding the company's obligations under SEBI's debt securities framework and clarifies its current status vis-à-vis large corporate classification requirements.